mTOR complex inhibition as a novel therapeutic strategy in high grade papillary serous ovarian cancer

被引：0
|
作者：
Musa, F. [1 ]
Alard, A. [2 ]
Blank, S. [1 ]
Pothuri, B. [1 ]
Curtin, J. [1 ]
Schneider, R. [1 ]
机构：
[1] NYU, Sch Med, New York, NY USA
[2] NYU, Sackler Inst Biomed Sci, New York, NY USA
来源：
GYNECOLOGIC ONCOLOGY | 2014年 / 134卷 / 02期
关键词：
D O I：
10.1016/j.ygyno.2014.04.032
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
14
引用
收藏
页码：434 / 435
页数：2
相关论文
共 50 条
  • [21] Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer
    Konecny, Gottfried E.
    Wang, Chen
    Hamidi, Habib
    Winterhoff, Boris
    Kalli, Kimberly R.
    Dering, Judy
    Ginther, Charles
    Chen, Hsiao-Wang
    Dowdy, Sean
    Cliby, William
    Gostout, Bobbie
    Podratz, Karl C.
    Keeney, Gary
    Wang, He-Jing
    Hartmann, Lynn C.
    Slamon, Dennis J.
    Goode, Ellen L.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (10):
  • [22] IDENTIFICATION OF NOVEL CHROMOSOMAL REARRANGEMENTS IN HIGH-GRADE SEROUS OVARIAN CANCER
    Sarvilinna, Nanna
    Pradhan, Barun
    Faisal, Imrul
    Tumiati, Manuela
    Alkodsi, Amjad
    Kauppi, Liisa
    CLINICAL CANCER RESEARCH, 2019, 25 (22) : 114 - 114
  • [23] Fallopian tube initiation of high grade serous ovarian cancer and ovarian metastasis: Mechanisms and therapeutic implications
    Bergsten, Tova M.
    Burdette, Joanna E.
    Dean, Matthew
    CANCER LETTERS, 2020, 476 : 152 - 160
  • [24] In tumor screening for novel targets in papillary serous ovarian cancer
    Baratta, Maria Giuseppina
    Baratta, Maria Giuseppina
    Liu, Joyce
    Liu, Joyce
    Zwang, Yaara
    Zwang, Yaara
    Zwang, Yaara
    Schinzel, Anna
    Schinzel, Anna
    Drapkin, Ronny
    Drapkin, Ronny
    Hahn, William
    Hahn, William
    Hahn, William
    Livingston, David M.
    Livingston, David M.
    CLINICAL CANCER RESEARCH, 2013, 19
  • [25] Expression of Galectins in high grade serous ovarian cancer
    Labrie, Marilyne
    Communal, Laudine
    Vladoiu, Maria-Claudia
    Dupont, Pascal
    Mes-Masson, Anne-Marie
    St-Pierre, Yves
    CANCER RESEARCH, 2016, 76
  • [26] Reversing chemoresistance in high grade serous ovarian cancer
    Saxena, Jayeta
    Nicolini, Francesco
    Lockley, Michelle
    CANCER RESEARCH, 2019, 79 (13)
  • [27] ELUCIDATING RESISTANCE MECHANISM TO PARP INHIBITORS FOR THE DEVELOPMENT OF NOVEL THERAPEUTIC APPROACHES IN HIGH-GRADE SEROUS OVARIAN CANCER
    Kulbe, Hagen
    Kassuhn, Wanja
    Ringel, Frauke
    Welsch, Gabriele
    Treffkorn, Peggy
    Taube, Eliane
    Horst, David
    Sehouli, Jalid
    Braicu, Elena
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A79 - A79
  • [28] Methylomic Signatures of High Grade Serous Ovarian Cancer
    Cardenas, Horacio
    Fang, Fang
    Jiang, Guanglong
    Perkins, Susan M.
    Zhang, Chi
    Emerson, Robert E.
    Hutchins, George
    Keer, Harold N.
    Liu, Yunlong
    Matei, Daniela
    Nephew, Kenneth
    EPIGENETICS, 2021, 16 (11) : 1201 - 1216
  • [29] Phylogenetic portraits of high grade serous ovarian cancer
    McPherson, Andrew
    Roth, Andrew
    Huntsman, David
    McAlpine, Jessica
    Shah, Sohrab
    CLINICAL CANCER RESEARCH, 2015, 21
  • [30] The Tumor Microenvironment of High Grade Serous Ovarian Cancer
    Stack, M. Sharon
    Nephew, Kenneth P.
    Burdette, Joanna E.
    Mitra, Anirban K.
    CANCERS, 2019, 11 (01):
12345